DrayNow, Inc., founded in 2017 and based in Pipersville, Pennsylvania, operates as a technology company specializing in the intermodal freight sector. It offers a real-time online marketplace that connects intermediaries with carriers, facilitating the efficient management of intermodal freight transportation. By leveraging advanced technology, DrayNow enables users to maintain constant visibility of shipments, compare rates, view load details, and select available loads in real-time. This innovative platform optimizes the first and last mile of intermodal logistics, enhancing operational efficiency and helping companies achieve higher levels of capacity, service, and profitability.
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company based in New York that focuses on developing innovative treatments for central nervous system (CNS) diseases and chronic pain management. The company's lead product candidate, d-Methadone, is currently undergoing Phase II clinical trials for conditions such as depression and neuropathic pain. In addition to d-Methadone, Relmada is also working on LevoCap ER, an abuse-resistant formulation of levorphanol; BuTab, an oral version of buprenorphine; and MepiGel, a topical formulation of mepivacaine designated for orphan drug status. Founded in 2004, Relmada aims to address significant unmet medical needs within the pain management and CNS therapeutic areas through its diversified portfolio of drug candidates.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.